The Conversation

The Conversation, MPN Edition

From Our Partner, the Patient Empowerment Network 

 

 

 

 

 

“The Conversation, MPN Edition” focuses on polycythemia vera (PV) and features MPN experts Dr. Srdan Verstovsek from MD Anderson Cancer Center, Dr. Mark Heaney from Columbia University Medical Center, and Bob Rosen from the MPN Research Foundation. The guests discuss the evolving treatment landscape and the latest research for PV as well as the challenges patients face in managing their condition.

 

Research Studies for Polycythemia Vera

From “The Conversation, MPN Edition,” Dr. Srdan Verstovsek of MD Anderson Cancer Center, Dr. Mark Heaney of Columbia University Cancer Center, and Bob Rosen, Chair of MPN Research Foundation, discuss their views on observational studies and clinical trials, as well as how polycythemia vera (PV) patients should approach participation in research studies

Published:

Genetics and PV: What Does It All Mean?

From “The Conversation, MPN Edition,” Dr. Srdan Verstovsek of MD Anderson Cancer Center, Dr. Mark Heaney of Columbia University Cancer Center, and Bob Rosen, Chair of the MPN Research Foundation, respond to the question, "What do genetic discoveries mean for polycythemia vera (PV) patients?"

Published:

PV Treatment Decisions: Where Are We Headed?

The Conversation, MPN Edition continues with Dr. Srdan Verstovek of MD Anderson Cancer Center and Dr. Mark Heaney of Columbia University Cancer Center as they discuss personalized and expanded options for the treatment of polycythemia vera (PV).

Published:

Current and Future Treatments for Polycythemia Vera (PV)

From The Conversation, MPN edition, Andrew speaks with Dr. Srdan Verstovsek of MD Anderson Cancer Center and Dr. Mark Heaney of Columbia University Medical Center regarding current and investigational treatments for polycythemia vera (PV).

Published:


Page last updated on November 11, 2015